Rollins Inc.
ROL
$56.99
+3.02%
Rollins, Inc. is a global leader in route-based pest and termite control services, operating primarily under its flagship Orkin brand across North America and internationally. The company is a dominant market player in the residential pest control segment, leveraging its extensive service network and brand reputation to maintain a competitive edge. The current investor narrative revolves around the company's resilience as an essential service provider, with recent attention focused on its ability to navigate inflationary cost pressures and sustain its historically defensive growth profile, as evidenced by its latest quarterly revenue increase.…
ROL
Rollins Inc.
$56.99
Investment Opinion: Should I buy ROL Today?
Rating & Thesis: Hold. Rollins is a high-quality company trapped at an unsustainable valuation, with near-term risks from decelerating growth and margin pressure outweighing its long-term defensive attributes. The mixed analyst sentiment, including a recent downgrade, and the lack of a clear catalyst for multiple expansion support a neutral stance.
Supporting Evidence: The valuation is prohibitive, with a trailing P/E of 55.2x and a forward P/E of 39.3x, both at a significant premium to likely sector peers. While revenue growth remains positive at 9.7% YoY, it has decelerated sequentially. Profitability metrics are strong (14.0% net margin, 38.3% ROE) but showed quarterly volatility, with Q4 net income falling from $163.5M in Q3 to $116.4M. The stock trades at a 39% discount to its 52-week high, but this appears warranted given the fundamental headwinds rather than a clear value opportunity.
Risks & Conditions: The two biggest risks are further gross margin erosion and a decline in revenue growth below 8%. This Hold rating would upgrade to a Buy if the forward P/E compresses below 30x while growth stabilizes, or if the stock convincingly breaks above key technical resistance at $60 on sustained volume. It would downgrade to a Sell if revenue growth decelerates below 5% or if the Q4 gross margin compression proves not to be an anomaly. The stock is overvalued relative to its own history and sector, pricing in perfection that appears increasingly difficult to achieve.
Sign up to view all
ROL 12-Month Price Forecast
The investment case for Rollins is a clash between undeniable quality and excessive valuation. The company's defensive service model, high returns, and strong cash flow are hallmarks of a compounder. However, the stock's price already reflects this quality and more, leaving it vulnerable to disappointment. The path of least resistance appears to be sideways consolidation as the market waits for earnings to grow into the valuation or for the multiple to contract further. The stance would turn bullish on evidence of sustained margin recovery and growth stabilization; it would turn bearish on a breakdown below the $51.77 support level on high volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rollins Inc.'s 12-month outlook, with a consensus price target around $74.09 and implied upside of +30.0% versus the current price.
Average Target
$74.09
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$46 - $74
Analyst target range
Analyst coverage is limited, with only four analysts providing estimates, indicating this is a niche name with less institutional scrutiny. The consensus sentiment appears mixed, as recent institutional ratings show a distribution including Outperform, Overweight, Equal Weight, Hold, and Neutral actions, with one notable downgrade from Wells Fargo from Overweight to Equal Weight in February 2026. The average revenue estimate for the period is $5.41 billion, with a range from $5.28 billion to $5.47 billion, and the average EPS estimate is $1.77, ranging from $1.71 to $1.79. The limited number of analysts and the recent downgrade signal a degree of caution, with the wide target range for revenue and earnings reflecting uncertainty around the company's near-term growth trajectory amid a challenging operating environment.
Bulls vs Bears: ROL Investment Factors
The evidence currently tilts bearish, primarily due to the severe valuation premium colliding with decelerating growth and negative price momentum. While Rollins possesses undeniable strengths in profitability, cash flow, and business model defensiveness, the market appears to be repricing the stock from a premium growth multiple to one more reflective of its mature, single-digit growth profile. The single most important tension in the investment debate is whether the company's high-quality fundamentals and expected earnings growth can justify its extreme valuation multiples before further multiple compression occurs. The resolution of this tension—specifically, the trajectory of gross margins and revenue growth in upcoming quarters—will determine the stock's direction.
Bullish
- High Profitability & ROE: Rollins maintains robust profitability with a trailing net margin of 14.0% and an exceptional return on equity of 38.3%, indicating highly efficient capital allocation. This operational strength is a key differentiator in the service sector.
- Strong Free Cash Flow Generation: The company generated $650 million in free cash flow over the trailing twelve months, providing significant financial flexibility for dividends, share buybacks, or strategic acquisitions. This cash generation underpins its defensive business model.
- Defensive, Essential Service Business: As a pest control leader, Rollins provides an essential, non-discretionary service, contributing to its resilience. This is reflected in its below-market beta of 0.84, though it has not prevented recent underperformance.
- Solid Revenue Growth Trajectory: Q4 2025 revenue grew 9.7% year-over-year to $912.9 million, demonstrating continued demand. The revenue mix is balanced between residential ($405.0M) and commercial ($304.9M) segments, reducing concentration risk.
Bearish
- Extreme Valuation Premium: The stock trades at a steep premium with a trailing P/E of 55.2x, a Price-to-Sales of 7.73x, and an EV/EBITDA of 35.5x, all elevated for the consumer cyclical sector. This leaves little room for multiple expansion and heightens downside risk if growth falters.
- Decelerating Growth & Margin Pressure: Q4 revenue growth of 9.7% YoY decelerated from 11.9% in Q3. Concurrently, the Q4 gross margin compressed to 47.5% from 54.4% in Q3, indicating rising cost pressures that could threaten profitability.
- Pronounced Technical Downtrend: The stock is down 12.32% over three months and 1.40% over one year, severely underperforming the S&P 500. Trading near 39% of its 52-week range ($51.77-$66.14) signals persistent negative momentum and weak investor sentiment.
- Limited Analyst Coverage & Downgrade: With only four analysts covering the stock, it lacks broad institutional scrutiny. Sentiment is mixed, including a notable downgrade from Wells Fargo to Equal Weight in February 2026, reflecting caution on the near-term outlook.
ROL Technical Analysis
The stock is in a pronounced downtrend, having declined 12.32% over the past three months and 1.40% over the past year, significantly underperforming the S&P 500, which gained 34.9% and 2.67% over the same periods, respectively. With a current price of $55.00, the stock is trading at approximately 39% of its 52-week range ($51.77 to $66.14), positioning it much closer to its lows and suggesting a potential value opportunity, though the persistent downtrend indicates significant negative momentum. Recent short-term momentum shows a modest 2.02% gain over the past month, which diverges from the longer-term weakness and could signal a tentative stabilization or a dead-cat bounce; however, this positive move is still dwarfed by the S&P 500's 7.36% gain over the same period, resulting in a relative strength reading of -5.34%. Key technical support is clearly defined at the 52-week low of $51.77, while resistance lies at the recent high of $66.14; a decisive break below support could trigger further selling, while a recovery above the $60 level would be needed to suggest a more durable reversal. The stock's beta of 0.84 indicates it is 16% less volatile than the broader market, which is typical for a defensive business but has not shielded it from recent underperformance.
Beta
0.84
0.84x market volatility
Max Drawdown
-20.0%
Largest decline past year
52-Week Range
$52-$66
Price range past year
Annual Return
+3.8%
Cumulative gain past year
| Period | ROL Return | S&P 500 |
|---|---|---|
| 1m | +6.9% | +8.5% |
| 3m | -9.4% | +2.8% |
| 6m | +0.7% | +4.6% |
| 1y | +3.8% | +32.3% |
| ytd | -3.4% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ROL Fundamental Analysis
Revenue growth remains positive but has decelerated, with Q4 2025 revenue of $912.9 million representing a 9.7% year-over-year increase; however, this growth rate is down from the stronger double-digit increases seen in prior quarters of 2025, such as the 11.9% YoY growth in Q3. The business is segmented, with Residential Contract Revenue of $405.0 million and Commercial Contract Revenue of $304.9 million in the latest period, indicating a balanced revenue mix. The company is highly profitable, posting Q4 net income of $116.4 million and a trailing net margin of 14.0%, though quarterly profitability can be volatile as seen in the sequential decline from Q3's net income of $163.5 million. Gross margin for Q4 was 47.5%, which is healthy for a service business but down from the 54.4% reported in Q3, indicating some quarterly margin pressure, while the trailing operating margin stands at a robust 19.4%. The balance sheet is solid with a debt-to-equity ratio of 0.97, indicating moderate leverage, and the company generated substantial free cash flow of $650.0 million over the trailing twelve months. With a return on equity of 38.3% and a current ratio of 0.60, the company is highly efficient at generating shareholder returns but maintains a relatively low liquidity position, which is typical for its asset-light service model.
Quarterly Revenue
$912913000.0B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$650021000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ROL Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 55.2x and a forward P/E of 39.3x, with the significant gap indicating the market expects substantial earnings growth in the coming year. Compared to sector averages, Rollins trades at a steep premium, as evidenced by its Price-to-Sales ratio of 7.73x and EV/EBITDA of 35.5x, which are elevated for the consumer cyclical sector and reflect its status as a high-quality, defensive growth name. Historically, the current trailing P/E of 55.2x is near the upper end of its own historical range observed over recent quarters, which has fluctuated between the mid-40s and low-60s, suggesting the stock is pricing in optimistic expectations despite its recent price decline, leaving little room for multiple expansion.
PE
55.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 36x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Rollins faces margin pressure, as evidenced by the Q4 2025 gross margin decline to 47.5% from 54.4% in Q3, which could erode its high profitability if wage and chemical cost inflation persist. The company's valuation is heavily dependent on sustaining growth; a further deceleration from the current 9.7% YoY rate could trigger significant multiple compression given its lofty P/E of 55.2x. While free cash flow is strong, the low current ratio of 0.60 and debt-to-equity of 0.97 indicate limited liquidity cushion and moderate leverage, which could constrain financial flexibility in a downturn.
Market & Competitive Risks: The primary market risk is valuation compression. Trading at a P/S of 7.73x and EV/EBITDA of 35.5x—a large premium to sector averages—the stock is vulnerable to a derating if investor appetite for quality defensives wanes or if growth stocks fall out of favor. The stock's beta of 0.84 confirms its defensive nature but has not prevented a 12.3% decline over three months amid a rising market, indicating company-specific concerns are outweighing its low market correlation. Competitive risks, while muted due to its strong brand, include potential market share erosion to smaller, more agile operators or DIY solutions.
Worst-Case Scenario: The worst-case scenario involves a combination of sustained margin compression, revenue growth falling below 5%, and a broader market sell-off in expensive stocks. This could lead analysts to slash forward EPS estimates, triggering a valuation derating towards its historical P/E lows. A realistic downside target aligns with the 52-week low of $51.77, representing a potential loss of approximately -6% from the current $55.00 price. A more severe bear case, incorporating a failed technical support break, could see a drawdown towards the $48-$50 range, implying a -10% to -13% loss.
FAQ
The key risks are, in order of severity: 1) Valuation Compression: The extreme P/E multiple (55.2x) could contract sharply if growth slows, posing a major downside risk. 2) Margin Erosion: Q4 gross margin fell to 47.5% from 54.4%; persistent cost inflation could permanently impair profitability. 3) Slowing Growth: Revenue growth decelerated to 9.7% YoY; a further slowdown would undermine the growth premium. 4) Technical Weakness: The stock is down 12.3% over three months and trading near its lows, indicating poor momentum and sentiment.
Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading between $55 and $60, as modest growth meets gradual multiple compression. The Bull Case (25% probability) targets $64-$66, requiring margin recovery and re-accelerated growth. The Bear Case (15% probability) warns of a drop to $51-$54 if margins worsen and growth stalls. The base case is most likely, implying a relatively flat total return from the current $55 price, with downside bias.
ROL is significantly overvalued relative to standard metrics. Its trailing P/E of 55.2x and Price-to-Sales of 7.73x are at a steep premium to the consumer cyclical sector, and its forward P/E of 39.3x still implies lofty growth expectations. Historically, the current P/E is at the upper end of its own range. The valuation implies the market expects sustained high-single-digit to low-double-digit earnings growth with no margin deterioration, a scenario that appears increasingly challenged.
ROL is not a compelling buy at current levels for most investors. While the company is fundamentally strong with a 38.3% ROE and $650M in annual free cash flow, the stock trades at a prohibitive trailing P/E of 55.2x, leaving minimal margin for error. The 9.7% revenue growth is decelerating, and the stock is in a clear downtrend. It could be a good buy for a very patient, valuation-insensitive investor seeking a defensive compounder, but only on a significant pullback towards the $51-$53 support zone.
ROL is unsuitable for short-term trading due to its low beta (0.84), negative momentum, and lack of near-term catalysts. It is theoretically a long-term compounder given its high ROE and defensive business, but the current overvaluation makes even a long-term entry point unattractive. Existing holders with a long-term horizon may choose to hold for quality, but new investors should wait for a better valuation entry point. A minimum suggested holding period, if purchased at a fair value, would be 3-5 years to allow the business growth to overcome valuation headwinds.